the obvious reason: their big-spending pharmaceutical advertisers would drop them like hot potatoes..
the report called this �one of the most significant perils to humans resulting from human activity.�.
despite neutral imaging results, adalimumab did improve other key markers of inflammation in the blood including glyca, crp, tnf, and il-6.. march 2015 (25)......rewards ., and bones, and it�s not clear how the drugs will affect them after long-term use.